CreditAccess Grameen Reports Strong Q3FY26 Recovery with 353% Profit Growth
CreditAccess Grameen Limited reported exceptional Q3FY26 results with net profit surging 353% year-on-year to ₹252.09 crore, recovering from a ₹99.52 crore loss in Q3FY25. Total income grew 7.92% to ₹1,491.31 crore while impairment provisions declined significantly to ₹342.57 crore. The Board approved 9,12,500 stock options for employees with an exercise price of ₹1,344.97. Strong regulatory metrics include CRAR of 26.44% and LCR of 195.89%.

*this image is generated using AI for illustrative purposes only.
CreditAccess Grameen Limited has delivered a remarkable turnaround in its third quarter FY26 performance, reporting exceptional growth across key financial metrics. The microfinance company's Board of Directors approved the quarterly results on January 20, 2026, showcasing a strong recovery from the previous year's challenges.
Financial Performance Highlights
The company's financial performance demonstrated significant improvement across all major parameters. The transformation from losses to substantial profits reflects the company's operational efficiency and market recovery.
| Metric | Q3 FY26 | Q3 FY25 | Change (%) |
|---|---|---|---|
| Total Income | ₹1,491.31 cr | ₹1,381.93 cr | +7.92% |
| Interest Income | ₹1,434.98 cr | ₹1,337.62 cr | +7.28% |
| Net Profit | ₹252.09 cr | ₹(99.52) cr | +353.26% |
| Basic EPS | ₹15.76 | ₹(6.24) | +352.56% |
| Diluted EPS | ₹15.68 | ₹(6.24) | +351.28% |
Operational Efficiency and Cost Management
The company's operational metrics showed substantial improvement, particularly in asset quality and provisioning. Total expenses decreased to ₹1,153.39 crore from ₹1,510.86 crore in the corresponding quarter of the previous year, representing a significant 23.65% reduction.
Impairment on financial instruments declined dramatically to ₹342.57 crore from ₹751.86 crore year-on-year, indicating improved asset quality and collection efficiency. Finance costs also decreased to ₹459.34 crore compared to ₹474.87 crore in Q3FY25, demonstrating better cost of funds management.
Nine-Month Performance Analysis
For the nine months ended December 31, 2025, CreditAccess Grameen maintained strong performance momentum with consistent profitability and growth.
| Parameter | 9M FY26 | 9M FY25 | Variance |
|---|---|---|---|
| Total Revenue | ₹4,461.65 cr | ₹4,345.70 cr | +2.67% |
| Net Profit | ₹438.09 cr | ₹484.19 cr | -9.52% |
| Basic EPS | ₹27.41 | ₹30.37 | -9.75% |
| Employee Expenses | ₹667.38 cr | ₹555.00 cr | +20.25% |
Employee Stock Option Plan Approval
The Board approved the grant of 9,12,500 stock options to eligible employees under the CAGL Employees Stock Option Plan – 2011. The exercise price has been set at ₹1,344.97 based on the daily average market price during the three months prior to the grant month.
| ESOP Details | Specifications |
|---|---|
| Total Options Granted | 9,12,500 |
| Exercise Price | ₹1,344.97 |
| Vesting Schedule | 25% annually over 4 years |
| Exercise Period | 36 months from vesting |
| Diluted EPS Impact | ₹15.68 |
Asset Quality and Regulatory Metrics
The company maintained strong regulatory compliance with robust capital adequacy and asset quality indicators. The Capital to Risk-Weighted Assets Ratio (CRAR) stood at 26.44%, well above regulatory requirements. Gross Stage III assets were contained at 4.04% with a provision coverage ratio of 67.22%.
The Liquidity Coverage Ratio (LCR) for Q3FY26 was reported at 195.89%, indicating strong liquidity management. The debt-equity ratio of 2.79 reflects a balanced capital structure for the NBFC's operations.
Business Segment and Geographic Focus
CreditAccess Grameen operates in a single business segment focused on lending to borrowers with similar risk profiles. The company maintains its geographic concentration in the domestic Indian market, serving microfinance and retail finance customers through its GrameenKoota brand.
During the quarter, the company allotted 2,01,381 equity shares upon exercise of employee stock options, compared to 1,08,978 shares in the corresponding quarter of the previous year. For the nine-month period, 3,60,383 shares were allotted against option exercises.
Source: CreditAccess Grameen Limited
Historical Stock Returns for Credit Access Grameen
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.08% | -3.76% | -2.91% | -2.13% | +24.32% | +65.68% |













































